Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indivior Pharmaceuticals Inc. Common Stock (INDV) vs Virgin Galactic Holdings, Inc. (SPCE) Price & Performance

Indivior Pharmaceuticals Inc. Common StockTrade
Virgin Galactic Holdings, Inc.Trade

Price performance (Past 24H)

Key statistics

Indivior Pharmaceuticals Inc. Common Stock vs Virgin Galactic Holdings, Inc. — how do they compare? Indivior Pharmaceuticals Inc. Common Stock trades at $34.3 (market cap $4.18B), while Virgin Galactic Holdings, Inc. trades at $2.54 (market cap $398.70M). The key difference: Indivior Pharmaceuticals Inc. Common Stock is far larger — about 10.5× Virgin Galactic Holdings, Inc.'s market cap, and Indivior Pharmaceuticals Inc. Common Stock is trading nearer its 52-week high, Virgin Galactic Holdings, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Indivior Pharmaceuticals Inc. Common Stock for 0 Days and Virgin Galactic Holdings, Inc. for 70 Days on average.

INDVSPCE
Market Cap
$4.18B$398.70M
Volume
1,819,7465,790,856
Sector
HealthIndustrials
52-Week High
$41.83$7.52
52-Week Low
$24.09$2.17
Typical Hold Time
0 Days70 Days
Enterprise Value
$4.47B$362.68M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Indivior Pharmaceuticals Inc. Common Stock

No Aura AI signal available yet.

Virgin Galactic Holdings, Inc.

Virgin Galactic (SPCE) trades at $2.63, down 1.5% today, reflecting ongoing investor concerns despite recent earnings beats. The company shows deteriorating fundamentals with negative profit margins and cash flow, though technical indicators suggest potential oversold conditions with RSI readings below 11. Recent news highlights commercial flight delays to 2027 but strong ticket demand, creating mixed sentiment among analysts.

Outlook remains highly speculative with significant execution risks. The path to profitability depends on successful Delta flight commercialization in 2027, but persistent cash burn and high short interest (near 30%) pose substantial downside risks. Analyst consensus is divided, reflecting the binary nature of SPCE's space tourism business model.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

INDV
100% Buy0% Sell
Avg holding period · 0 Days
SPCE
0% Buy100% Sell
Avg holding period · 70 Days

Top news

Latest headlines on both assets

About Indivior Pharmaceuticals Inc. Common Stock

Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.

Read more on INDV →

About Virgin Galactic Holdings, Inc.

Virgin Galactic Holdings Inc. develops space vehicles. The Company designs exploration technology such as missiles, rockets, and other related equipment. Virgin Galactic Holdings serves customers in the United States.

Read more on SPCE →